Last edition
News about "Binish Chudgar"
Bio-Thera Expands Partnership with Intas for BAT2506 Biosimilar in India
Bio-Thera has expanded its partnership with Intas Pharmaceuticals to commercialise BAT2506, a proposed golimumab biosimilar, in India.
Binish Chudgar | 24/03/2026 | By News Bureau
Intas Pharmaceuticals Acquires UDENYCA from Coherus BioSciences
Intas Pharmaceuticals, along with its global subsidiaries operating under the Accord brand, has acquired UDENYCA (pegfilgrastim-cbqv) from Coherus BioSciences, strengthening its global biosimilar portfolio and strengthening its position in the pegfilgrastim market.
Binish Chudgar | 07/08/2025 | By Mrinmoy Dey | 263
Intas Pharmaceuticals has launched HETRONIFLY (Serplulimab), the world’s first PD-1 inhibitor approved for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in the Indian market.
Binish Chudgar | 06/08/2025 | By Mrinmoy Dey | 362
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy